Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
MapLight Therapeutics, Inc. (MPLT) is the subject of an amended beneficial-ownership report in which Forbion Growth Opportunities Fund III Cooperatief U.A. reports directly owning 4,428,328 voting common shares. Forbion Growth III Management B.V., as director of the fund, may be deemed to have voting and investment power over those same shares.
Both reporting persons report shared voting and dispositive power over 4,428,328 shares, representing approximately 8.4% of the outstanding voting common stock. The percentage is based on 52,848,208 shares outstanding, as reported in MapLight’s prospectus filed September 23, 2026.
Key Figures
Shares beneficially owned:4,428,328 sharesPercentage of outstanding voting common stock:Approximately 8.4%Voting common stock outstanding:52,848,208 shares
3 metrics
Shares beneficially owned4,428,328 sharesReported by each reporting person; the fund directly owns the shares.
Percentage of outstanding voting common stockApproximately 8.4%Reported by each reporting person.
Voting common stock outstanding52,848,208 sharesReported in MapLight’s prospectus filed September 23, 2026; used as the basis for the reported percentage.
Key Terms
investment power, shared voting power, shared dispositive power
3 terms
investment powerregulatory
"may be deemed to have voting and investment power"
shared voting powerregulatory
"Shared voting power 4,428,328"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive powerregulatory
"Shared dispositive power 4,428,328"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many MPLT shares do the Forbion Growth III entities report?
Forbion Growth Opportunities Fund III Cooperatief U.A. directly owns 4,428,328 shares, and Forbion Growth III Management B.V. may be deemed to have voting and investment power over those same shares as the fund’s director.
What percentage of MPLT does Forbion report owning?
The reporting persons report approximately 8.4% of MapLight’s outstanding voting common stock, based on 52,848,208 shares outstanding as reported in the issuer’s prospectus filed September 23, 2026.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
MapLight Therapeutics, Inc.
(Name of Issuer)
Voting Common Stock, par value $0.0001 per share
(Title of Class of Securities)
56565P103
(CUSIP Number)
09/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
56565P103
1
Names of Reporting Persons
Forbion Growth Opportunities Fund III Cooperatief U.A.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
NETHERLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
4,428,328.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
4,428,328.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
4,428,328.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.4 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
56565P103
1
Names of Reporting Persons
Forbion Growth III Management B.V.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
NETHERLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
4,428,328.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
4,428,328.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
4,428,328.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.4 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
MapLight Therapeutics, Inc.
(b)
Address of issuer's principal executive offices:
800 CHESAPEAKE DRIVE, REDWOOD CITY, CA 94063
Item 2.
(a)
Name of person filing:
This statement is being filed by Forbion Growth Opportunities Fund III Cooperatief U.A. ("Forbion Growth III COOP") and Forbion Growth III Management B.V. ("Forbion Growth III"). Forbion Growth III COOP and Forbion Growth III are sometimes referred to collectively as the "Reporting Persons".
(b)
Address or principal business office or, if none, residence:
The address of the principal business and principal office of each of the Reporting Persons is c/o Forbion Capital Partners, Gooimeer 2-35, 1411 DC Naarden, The Netherlands.
(c)
Citizenship:
Each of the Reporting Persons is organized under the laws of the Netherlands.
(d)
Title of class of securities:
Voting Common Stock, par value $0.0001 per share
(e)
CUSIP No.:
56565P103
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
Forbion Growth III COOP directly owns 4,428,328 shares of Common Stock of the Issuer. Forbion Growth III, as the director of Forbion Growth III COOP, may be deemed to have voting and investment power over the shares held directly by Forbion Growth III COOP.
(b)
Percent of class:
The shares of Common Stock beneficially owned by the Reporting Persons represent approximately 8.4% of the outstanding voting Common Stock, based upon 52,848,208 shares of voting Common Stock outstanding, as reported in the Issuer's prospectus filed pursuant to Rule 424(b)(3) on September 23, 2026.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
4,428,328
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
4,428,328
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
Not Applicable
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Forbion Growth Opportunities Fund III Cooperatief U.A.